These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33637230)

  • 1. Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa study.
    Kucher K; Johns D; Wagner F; Abd-Elaziz K; Derne C; Sverdlov O; Pfister CU; Langguth B
    Prog Brain Res; 2021; 260():423-440. PubMed ID: 33637230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationship.
    Kasteleijn-Nolst Trenité D; Brandt C; Mayer T; Rosenow F; Schmidt B; Steinhoff BJ; Gardin A; Imbert G; Johns D; Sagkriotis A; Kucher K
    Epilepsia; 2015 Jun; 56(6):924-32. PubMed ID: 25963722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BGG492 as an adjunctive treatment in patients with partial-onset seizures: A 12-week, randomized, double-blind, placebo-controlled, phase II dose-titration study with an open-label extension.
    Elger CE; Hong SB; Brandt C; Mancione L; Han J; Strohmaier C
    Epilepsia; 2017 Jul; 58(7):1217-1226. PubMed ID: 28500678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.
    Gomez-Mancilla B; Brand R; Jürgens TP; Göbel H; Sommer C; Straube A; Evers S; Sommer M; Campos V; Kalkman HO; Hariry S; Pezous N; Johns D; Diener HC;
    Cephalalgia; 2014 Feb; 34(2):103-13. PubMed ID: 23963355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitus.
    Searchfield GD; Robinson JM; Skarinsky D; Wang Y; Anderson JJ
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5307-5318. PubMed ID: 37341760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus.
    Suckfüll M; Althaus M; Ellers-Lenz B; Gebauer A; Görtelmeyer R; Jastreboff PJ; Moebius HJ; Rosenberg T; Russ H; Wirth Y; Krueger H
    BMC Ear Nose Throat Disord; 2011 Jan; 11():1. PubMed ID: 21223542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study.
    Maxwell KS; Robinson JM; Hoffmann I; Hou HJ; Searchfield G; Baguley DM; McMurry G; Piu F; Anderson JJ
    Otol Neurotol; 2021 Dec; 42(10):e1625-e1633. PubMed ID: 34629442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy.
    Faught E
    Expert Opin Investig Drugs; 2014 Jan; 23(1):107-13. PubMed ID: 24147649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a 4-Week Treatment with Cilostazol in Patients with Chronic Tinnitus: A Randomized, Prospective, Placebo-controlled, Double-blind, Pilot Study.
    Lim HW; Kim TS; Kang WS; Song CI; Baek S; Chung JW
    J Int Adv Otol; 2016 Aug; 12(2):170-176. PubMed ID: 27716604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Placebo-Controlled, Double-Blind, Parallel Groups Study Evaluating the Performance and Safety of a Steady State Coherent Biomodulator Patch in the Treatment of Subjective Tinnitus.
    Ahnblad P; Nordkvist A
    Int Tinnitus J; 2017 Dec; 21(2):157-167. PubMed ID: 29336135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A double-blind randomized controlled trial on the efficacy of mixed pure tone sound therapy in chronic tinnitus patients with different hearing loss].
    Li Y; Feng GD; Wu HY; Gao ZQ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 54(5):355-361. PubMed ID: 31137095
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus--a double-blind, randomized, placebo-controlled phase II study.
    van de Heyning P; Muehlmeier G; Cox T; Lisowska G; Maier H; Morawski K; Meyer T
    Otol Neurotol; 2014 Apr; 35(4):589-97. PubMed ID: 24603353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study.
    Taslimi S; Vahidi H; Pourvaziri A; Modabbernia A; Fallah AY; Yazdani N; Taslimi N; Hosseini M; Zarandi MM
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1635-41. PubMed ID: 23001433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sertraline on severe tinnitus suffering--a randomized, double-blind, placebo-controlled study.
    Zöger S; Svedlund J; Holgers KM
    J Clin Psychopharmacol; 2006 Feb; 26(1):32-9. PubMed ID: 16415703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effect of intratympanic dexamethasone injection in acute unilateral tinnitus: A prospective, placebo-controlled, multicenter study.
    Lee HJ; Kim MB; Yoo SY; Park SN; Nam EC; Moon IS; Lee HK
    Laryngoscope; 2018 Jan; 128(1):184-188. PubMed ID: 28224644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of transmeatal low-power laser stimulation in treating tinnitus.
    Ngao CF; Tan TS; Narayanan P; Raman R
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):975-80. PubMed ID: 23605244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study on the efficacy and safety of low level light therapy in the management of cochlear tinnitus: A single blind randomized clinical trial.
    Choi JE; Lee MY; Chung PS; Jung JY
    Int Tinnitus J; 2019 Jan; 23(1):52-57. PubMed ID: 31469529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Trimetazidine Dihydrochloride for Relieving Chronic Tinnitus: A Randomized Double-Blind Study.
    Kumral TL; Yıldırım G; Berkiten G; Saltürk Z; Ataç E; Atar Y; Uyar Y
    Clin Exp Otorhinolaryngol; 2016 Sep; 9(3):192-7. PubMed ID: 27230273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The low-power laser in the treatment of tinnitus.
    Mirz F; Zachariae R; Andersen SE; Nielsen AG; Johansen LV; Bjerring P; Pedersen CB
    Clin Otolaryngol Allied Sci; 1999 Aug; 24(4):346-54. PubMed ID: 10472473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric evaluation of visual analog scale for the assessment of chronic tinnitus.
    Adamchic I; Langguth B; Hauptmann C; Tass PA
    Am J Audiol; 2012 Dec; 21(2):215-25. PubMed ID: 22846637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.